Skip to main content

and
  1. No Access

    Article

    Is there any place for novel agents in treating biliary tract cancer?

    Biliary tract cancer is an uncommon cancer in developed countries. In localized stages, surgery is the cornerstone of treatment with curative purpose. Conversely in advanced stages, chemotherapy with platinum–...

    Gianluca Perego, Valentina Burgio, Renata Nozza, Giorgia Longobardo in Medical Oncology (2021)

  2. No Access

    Article

    A systematic review of salvage therapies in refractory metastatic colorectal cancer

    Established that the only approved agents in previously treated metastatic colorectal cancer (CRC) are trifluoridine/tipiracil and regorafenib, we conducted a systematic review of all the published phase 2–3 t...

    Fausto Petrelli, Gianluca Perego in International Journal of Colorectal Disease (2020)